[Ac-225]Ac-SibuDAB for Targeted Alpha Therapy of Prostate Cancer: Preclinical Evaluation and Comparison with [Ac-225]Ac-PSMA-617

Busslinger, SD; Tschan, VJ; Richard, OK; Talip, Z; Schibli, R; Muller, C

Muller, C (通讯作者),Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI, Forsch Str 111, CH-5232 Villigen, Switzerland.;Muller, C (通讯作者),Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.

CANCERS, 2022; 14 (22):

Abstract

Simple Summary Prostate-specific membrane antigen (PSMA) radioligands have proven effective to treat patients with metastatic castration-resistant pro......

Full Text Link